Navigation Links
Drug to treat lung cancer shows promise

A pill long used around the world to treat dry mouth could help protect against lung cancer in lifelong smokers. The drug appears especially promising for former smokers, who still face a higher-than-usual risk// of lung cancers years after they quit. The preliminary study found that the medicine reduced the risk of new or worsening precancerous growths in the lungs of longtime smokers by about 30% during 7 months of use.

The drug, made by the French company Solvay Pharma, is not available in the US. It is sold in Canada, Europe, China and other countries as Sialor or Sulfarlem and has been on the market for 30 years. The drug appears to work by increasing the body's levels of an enzyme called Gst that ordinarily detoxifies dangerous substances, such as tobacco smoke. Levels of this enzyme can be abnormally low in people long exposed to tobacco.

Experts say large-scale testing will be necessary to show that the approach truly lowers the risk of lung cancer, but they say the latest findings make biological sense. "It's an intriguing, promising finding in a small patient population. When people give up smoking, they retain a substantial risk of lung cancer. Half of newly diagnosed lung cancer is in former smokers. The challenge is helping these people lower their risk." said Dr. Frank J. Rauscher III of the Wistar Institute in Philadelphia.
'"/>




Page: 1

Related medicine news :

1. Thyroid hormone treatment hastens recovery after cardiac surgery
2. Feeding channel created by malaria parasite - a new target for malaria treatments
3. New drug to treat Heart Attack and damaged tissue
4. Now umbilical cord helps in stroke treatment.
5. Now AIDS treatment comes dirt-cheap
6. Breast cancer treatment to be determined by gene test
7. Hemopurifier may revolutionise AIDS treatment
8. New drug helps boost cancer treatment
9. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
10. Experimental treatment for Ebola Virus Shows promising results in mice
11. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/17/2017)... ... January 17, 2017 , ... ... lecture to primary eye care practitioners on the latest breakthroughs in the prevention, ... Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey Martin, MD, FACS, Chief ...
(Date:1/17/2017)... , ... January 17, 2017 , ... Neil H. Greco ... planning assistance to communities throughout the region, is launching a charity drive to raise ... is by far the deadliest killer in America, and is responsible for 1 in ...
(Date:1/17/2017)... Los Gatos, CA (PRWEB) , ... January 17, 2017 , ... ... today announced the results of a double blind clinical study for its dental gel ... to a leading national brand of toothpaste containing triclosan. The study was conducted at ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... from two offices in Tyler, has announced the latest beneficiary of their thriving ... Network, a nonprofit organization dedicated to fulfilling the dreams of terminally ill patients. ...
(Date:1/17/2017)... ... ... Today, FloSports , a global leader in live digital sports and original ... long-term extension of their media partnership. The partnership, which began in 2013, will now ... events exclusively on FloWrestling.com as well as usage of the FloArena meet management software ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... 2017 In China , we ... the Upgrade of China,s Healthy Strategy ... Plan for Economic and Social Development of the ... and the state council of the People,s Republic ... emerging industry development plan, identifying medical devices as one of ...
(Date:1/18/2017)... Jan. 18, 2017  Tarix Orphan LLC today announced ... a Rare Pediatric Disease (RPD) designation for the company,s ... Epidermolysis Bullosa (RDEB), a rare genetic skin disorder. There ... is limited to supportive care. "The RPD ... Designation previously granted by the FDA in this indication," ...
(Date:1/18/2017)...  Robust competition in the private marketplace is resulting in ... to a new study by the Berkeley ... to examine the share of prescription medicine spending retained ... health plans and other stakeholders in the supply chain. ... show what happens when the list price of a ...
Breaking Medicine Technology: